Arzneiwerk AG VIDA Profit Margin

Arzneiwerk AG VIDA (TLIK.F) currently reports a profit margin of -57658.25% as of June 2026. That compares with 2.41% in the prior-year period — down 2388792.2% year over year. That is below the sector sector average of 13.23%. Use the charts on this page to explore Arzneiwerk AG VIDA's profit margin history and peer comparisons.

Arzneiwerk AG VIDA's profit margin decreased from 2.41% to -57658.25% — a 2388792.2% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Arzneiwerk AG VIDA's profit margin of -57658.25% is lower than the its sector sector average of 13.23%. That is roughly 436041.7% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Arzneiwerk AG VIDA's current -57658.25% should be judged against industry norms (sector average: 13.23%) and against TLIK.F's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -57658.25%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 13.23%. From there, open related valuation or income-statement pages for Arzneiwerk AG VIDA, and consider following TLIK.F for alerts when major investors trade the stock.